Foresite Capital Management V, LLC Diversified Active

Name: Foresite Capital Management V, LLC Q4 2020 13F Filing | 13F Explorer
Creator: Foresite Capital Management V, LLC
Published: 2021-02-16

Location: West Hollywood, CA

CIK: 0001792206 · Show all filings

Period: Q4 2020 (Next →)

Filing Date: Feb 16, 2021

Total Value: $135M (100.0% shares, 0.0% debt)

Holdings (12)

— Kinnate Biopharma Inc. 25.8%

Value $34.81M Shares 875,001 Est. Cost $39.78 Unrealized —

ALXO ALX Oncology Holdings Inc. 20.4%

Value $27.58M Shares 320,000 Est. Cost $60.15 Unrealized 0.0%

RLAY Relay Therapeutics, Inc. 12.3%

Value $16.62M Shares 400,000 Est. Cost $45.21 Unrealized 0.0%

NRIX Nurix Therapeutics, Inc. 11.0%

Value $14.85M Shares 451,522 Est. Cost $33.14 Unrealized 0.0%

— Oaktree Acquisition Corp. 9.4%

Value $12.72M Shares 871,422 Est. Cost $14.60 Unrealized —

— Population Health Investment Co., Inc. 7.4%

Value $10.03M Shares 960,000 Est. Cost $10.45 Unrealized —

— Therapeutics Acquisition Corp 3.6%

Value $4.872M Shares 350,000 Est. Cost $13.92 Unrealized —

— BCTG Acquisition Corp. 3.4%

Value $4.576M Shares 400,000 Est. Cost $11.44 Unrealized —

— LifeSci Acquisition II Corp. 3.2%

Value $4.268M Shares 400,000 Est. Cost $10.67 Unrealized —

MLTX Helix Acquisition Corp. 2.1%

Value $2.843M Shares 250,000 Est. Cost $11.37 Unrealized —

— Consonance-HFW Acquisition Corp. 0.8%

Value $1.047M Shares 100,000 Est. Cost $10.47 Unrealized —

ABCL Abcellera Biologics Inc. 0.6%

Value $805K Shares 20,000 Est. Cost $45.73 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Kinnate Biopharma Inc.	875,001	$34.81M	25.8%	$39.78	—	COM	49705R105
ALXO	ALX Oncology Holdings Inc.	320,000	$27.58M	20.4%	$60.15	0.0%	COM	00166B105
RLAY	Relay Therapeutics, Inc.	400,000	$16.62M	12.3%	$45.21	0.0%	COM	75943R102
NRIX	Nurix Therapeutics, Inc.	451,522	$14.85M	11.0%	$33.14	0.0%	COM	67080M103
—	Oaktree Acquisition Corp.	871,422	$12.72M	9.4%	$14.60	—	SHS CL A	G67145105
—	Population Health Investment Co., Inc.	960,000	$10.03M	7.4%	$10.45	—	UNIT	G71716123
—	Therapeutics Acquisition Corp	350,000	$4.872M	3.6%	$13.92	—	COM CL A	88339T103
—	BCTG Acquisition Corp.	400,000	$4.576M	3.4%	$11.44	—	COM	05492W103
—	LifeSci Acquisition II Corp.	400,000	$4.268M	3.2%	$10.67	—	COM	53229E103
MLTX	Helix Acquisition Corp.	250,000	$2.843M	2.1%	$11.37	—	COM CL A	G4444C102
—	Consonance-HFW Acquisition Corp.	100,000	$1.047M	0.8%	$10.47	—	UNIT	0G244M129
ABCL	Abcellera Biologics Inc.	20,000	$805K	0.6%	$45.73	0.0%	COM	00288U106